Alliance Discussion: Finding New Hope in Existing Drugs with Dr. David Fajgenbaum, Every Cure

Globally, there are millions of people diagnosed with diseases that have no available or approved treatments. Drug repurposing or using an approved drug as a new treatment for another disease has been an effective, but underutilized tool in therapeutic discovery. In February 2024, Every Cure received an ARPA-H Project Award to develop an AI-powered platform, called ML/AI-enabled Therapeutic Repurposing In eXtended uses (MATRIX). Co-Founder & President of Every Cure, Dr. David Fajgenbaum, joined us to share how he repurposed an existing drug to save his life and now is on a mission to unlock treatments for millions more using the power of AI.